These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 15537439)

  • 1. Osteoporosis prevalence and levels of treatment in primary care: the Australian BoneCare Study.
    Eisman J; Clapham S; Kehoe L;
    J Bone Miner Res; 2004 Dec; 19(12):1969-75. PubMed ID: 15537439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone health in women with premature ovarian insufficiency/early menopause: a 23-year longitudinal analysis.
    Jones AR; Enticott J; Ebeling PR; Mishra GD; Teede HT; Vincent AJ
    Hum Reprod; 2024 May; 39(5):1013-1022. PubMed ID: 38396142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of patients with postmenopausal osteoporosis in French primary healthcare.
    Blotman F; Cortet B; Hilliquin P; Avouac B; Allaert FA; Pouchain D; Gaudin AF; Cotté FE; El Hasnaoui A
    Drugs Aging; 2007; 24(7):603-14. PubMed ID: 17658910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
    McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between back pain and future vertebral fracture in postmenopausal women.
    Kuroda T; Shiraki M; Tanaka S; Shiraki Y; Narusawa K; Nakamura T
    Spine (Phila Pa 1976); 2009 Aug; 34(18):1984-9. PubMed ID: 19680106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis and fracture risk in women of different ethnic groups.
    Barrett-Connor E; Siris ES; Wehren LE; Miller PD; Abbott TA; Berger ML; Santora AC; Sherwood LM
    J Bone Miner Res; 2005 Feb; 20(2):185-94. PubMed ID: 15647811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ; Naganathan V; Barton I; Grauer A
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for osteoporosis related to their outcome: fractures.
    van der Voort DJ; Geusens PP; Dinant GJ
    Osteoporos Int; 2001; 12(8):630-8. PubMed ID: 11580076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
    Siris ES; Brenneman SK; Miller PD; Barrett-Connor E; Chen YT; Sherwood LM; Abbott TA
    J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
    Chesnut CH; Skag A; Christiansen C; Recker R; Stakkestad JA; Hoiseth A; Felsenberg D; Huss H; Gilbride J; Schimmer RC; Delmas PD;
    J Bone Miner Res; 2004 Aug; 19(8):1241-9. PubMed ID: 15231010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low bone mineral density, but not epidural steroid injection, is associated with fracture in postmenopausal women with low back pain.
    Yi Y; Hwang B; Son H; Cheong I
    Pain Physician; 2012; 15(6):441-9. PubMed ID: 23159959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for osteoporotic fractures and low bone density in pre and postmenopausal women.
    Pinheiro MM; Reis Neto ET; Machado FS; Omura F; Yang JH; Szejnfeld J; Szejnfeld VL
    Rev Saude Publica; 2010 Jun; 44(3):479-85. PubMed ID: 20549019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
    Liberman UA; Weiss SR; Bröll J; Minne HW; Quan H; Bell NH; Rodriguez-Portales J; Downs RW; Dequeker J; Favus M
    N Engl J Med; 1995 Nov; 333(22):1437-43. PubMed ID: 7477143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: the OFELY study.
    Albrand G; Munoz F; Sornay-Rendu E; DuBoeuf F; Delmas PD
    Bone; 2003 Jan; 32(1):78-85. PubMed ID: 12584039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal bilateral oophorectomy is not associated with increased fracture risk in older women.
    Antoniucci DM; Sellmeyer DE; Cauley JA; Ensrud KE; Schneider JL; Vesco KK; Cummings SR; Melton LJ;
    J Bone Miner Res; 2005 May; 20(5):741-7. PubMed ID: 15824846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex difference in the validity of vertebral deformities as an index of prevalent vertebral osteoporotic fractures: a population survey of older men and women.
    Leidig-Bruckner G; Limberg B; Felsenberg D; Bruckner T; Holder S; Kather A; Miksch J; Wüster C; Ziegler R; Scheidt-Nave C
    Osteoporos Int; 2000; 11(2):102-19. PubMed ID: 10793868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability.
    McCloskey EV; Fitzpatrick LA; Hu MY; Williams G; Kanis JA
    Arch Osteoporos; 2019 Feb; 14(1):15. PubMed ID: 30719589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA).
    Siris ES; Brenneman SK; Barrett-Connor E; Miller PD; Sajjan S; Berger ML; Chen YT
    Osteoporos Int; 2006; 17(4):565-74. PubMed ID: 16392027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis.
    Leder BZ; Mitlak B; Hu MY; Hattersley G; Bockman RS
    J Clin Endocrinol Metab; 2020 Mar; 105(3):938-43. PubMed ID: 31674644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.